The analyst is investing early in $CCXI as a core believer in robotics and humanoids, viewing it as a long-term opportunity despite the early stage of the industry.
The humanoid robotics industry is in its early commercialization phase with significant AI capex and VC funding expected; the analyst expects production volume to ramp up and supply chain companies to benefit, but conviction is still building as major players are in proof of concept stages.
Super interesting seeing everyone jumping in on the humanoid trade with $CCXI recently! Just important to remember that it's still extremely early: - Est. 2026 AI capex = ~$1 trillion - Est. 2026 humanoid VC funding = ~$70 billion Personally, I'm investing early as a core believer in robotics / humanoids. But I do kinda feel like you'd want to wait and see which OEM like Agility or Figure breaks out to become the de facto leader and go-to OEM as prodcution volume ramps up. For B2B customers like $AMZN, $MELI, and Toyota etc. Similar to $NVDA and GPUs. At that point, the upstream supply chain starts to open up where you'll see names like Harmonic Drive, Leaderdrive etc also have steeper volume/financial inflections especially if supply constrained (highly dependent on China). Personally, I've been waiting years for humanoids to enter the commercialization phase and wanna participate in that early. Just still very early to build conviction with the likes of Siemens / $TSLA still running proof of concept tests in a small number of factories. With a tail of other OEMs like "Humanoid" in the UK a couple gens behind the likes of Agility. And you've still got issues where it's taking some time to actually develop humanoid hands for more tricky tasks on top of moving boxes in warehouses etc. So then you've got a further commercial TAM expansion into fields like medical/research on top of logistics currently.
| Horizon | Raw move | vs SPY |
|---|---|---|
| 1 day | +12.0% | +12.1% |
| 1 week | -10.6% | -10.5% |
| 1 month | -18.8% | -18.9% |
| 3 months | — | — |
| 6 months | — | — |